ArticleTranslational lung cancer research2020

Non-alcoholic fatty liver disease is associated with immune checkpoint inhibitor-based treatment response in patients with non-small cell lung cancer with liver metastases.

Juan Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.